Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 03, 2024$58.88
P/E Ratio
5.18
Market Cap
$3.36B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Overview
Trading Information
Company